Published in Gene Therapy Weekly, November 4th, 2004
Joseph Wender is an advisory director and senior director of the Financial Institutions Group at the global investment banking firm, Goldman, Sachs & Co., and Michael Khoury is a financial advisor and independent consultant. These additions bring Neurome's total board membership to six.
Commenting on the new appointments to the Board, Floyd E. Bloom, MD, chairman of the board and founding chief executive officer of Neurome, remarked, "Wender and Khoury, both seasoned biotech investors and experienced financial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.